San Francisco, CA, October 23, 2023 – RCE Technologies, Inc. had the opportunity to go center stage and present an overview of the company’s innovative technology along with late breaking insights from recently conducted studies around continuous trending of cardiac injury biomarkers. These insights gained extend the clinical value of the wearable technology that was presented at the ACC-Late Breaking Clinical Trials by Dr.Partho Sengupta earlier this year, where he cast the vision of utility in trending continuous biomarkers.
RCE continues its scientific and clinical series of validation to advance its novel technology towards patient care.